ALAS-E Activators

ALAS-E Activators are chemical compounds that interact with ALAS-E directly or with the heme synthesis pathway, indirectly enhancing the functional activity of ALAS-E. Succinylacetone, an inhibitor of ALA dehydratase, can stimulate ALAS-E activity by causing accumulation of ALA. Similarly, 5-Aminolevulinic acid (ALA), the direct product of ALAS-E, provides feedback to stimulate ALAS-E activity. The trace elements iron and zinc, required for the synthesis of heme and as a co-factor of ALAS-E respectively, can enhance ALAS-E activity by increasing its efficiency or the demand for its product. Pyridoxal phosphate (PLP), the co-factor of ALAS-E, and the substrates of ALAS-E, glycine and succinyl-CoA, can directly augment ALAS-E activity by increasing its efficiency.

Glucocorticoids such as dexamethasone can enhance ALAS-E activity by increasing the expression of ALAS-E. N-acetylcysteine (NAC) can protect ALAS-E from oxidative damage, thus preserving its activity. Hemin, an end product of the heme synthesis pathway, signals the need for more heme, thus enhancing the activity of ALAS-E. Deferoxamine, an iron chelator, can also indirectly enhance ALAS-E activity by increasing the demand for heme synthesis. Lastly, Vitamin B6, the precursor of pyridoxal phosphate, can indirectly enhance ALAS-E activity by increasing the availability of its co-factor. These compounds, by directly interacting with ALAS-E or influencing the heme synthesis pathway, can enhance the functional activity of ALAS-E.